Nanoscale drug delivery for targeted chemotherapy

被引:91
作者
Xin, Yong [1 ]
Huang, Qian [2 ]
Tang, Jian-Qin [3 ]
Hou, Xiao-Yang [3 ]
Zhang, Pei [2 ]
Zhang, Long Zhen [1 ]
Jiang, Guan [3 ]
机构
[1] Affiliated Hosp Xuzhou Med Univ, Dept Radiotherapy, Xuzhou 221002, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Oncol, Xuzhou 221002, Jiangsu, Peoples R China
[3] Affiliated Hosp Xuzhou Med Univ, Dept Dermatol, Xuzhou 221002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Nanotechnology; Drug delivery system; Chemotherapy; Cancer therapy; LONG-CIRCULATING LIPOSOMES; BLOOD-BRAIN-BARRIER; GENE-THERAPY; CANCER-THERAPY; IN-VIVO; OPTICAL/PARAMAGNETIC NANOPROBE; MACROMOLECULAR THERAPEUTICS; TUMOR; NANOPARTICLES; RESISTANCE;
D O I
10.1016/j.canlet.2016.05.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite significant improvements in diagnostic methods and innovations in therapies for specific cancers, effective treatments for neoplastic diseases still represent major challenges. Nanotechnology as an emerging technology has been widely used in many fields and also provides a new opportunity for the targeted delivery of cancer drugs. Nanoscale delivery of chemotherapy drugs to the tumor site is highly desirable. Recent studies have shown that nanoscale drug delivery systems not only have the ability to destroy cancer cells but may also be carriers for chemotherapy drugs. Some studies have demonstrated that delivery of chemotherapy via nanoscale carriers has greater therapeutic benefit than either treatment modality alone. In this review, novel approaches to nanoscale delivery of chemotherapy are described and recent progress in this field is discussed. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 102 条
  • [1] Advances in Nano Drugs for Cancer Chemotherapy
    Ali, I.
    Rahis-Uddin
    Salim, K.
    Rajora, A. K.
    Rather, M. A.
    Wani, W. A.
    Haque, A.
    [J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 135 - 146
  • [2] Drug delivery systems: Entering the mainstream
    Allen, TM
    Cullis, PR
    [J]. SCIENCE, 2004, 303 (5665) : 1818 - 1822
  • [3] [Anonymous], 2014, Cent Eur J Public Health, V22, P28
  • [4] Natural immunity to cancer in humans
    Bindea, Gabriela
    Mlecnik, Bernhard
    Fridman, Wolf-Herman
    Pages, Franck
    Galon, Jerome
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (02) : 215 - 222
  • [5] CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
    Burger, J. A.
    Peled, A.
    [J]. LEUKEMIA, 2009, 23 (01) : 43 - 52
  • [6] Active targeting schemes for nanoparticle systems in cancer therapeutics
    Byrne, James D.
    Betancourt, Tania
    Brannon-Peppas, Lisa
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (15) : 1615 - 1626
  • [7] RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells
    Cai, Li-Li
    Liu, Ping
    Li, Xi
    Huang, Xuan
    Ye, Yi-Qing
    Chen, Feng-Ying
    Yuan, Hong
    Hu, Fu-Qiang
    Du, Yong-Zhong
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 3499 - 3508
  • [8] Micelles of different morphologies - Advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery
    Cai, Shenshen
    Vijayan, Kandaswamy
    Cheng, Debbie
    Lima, Eliana M.
    Discher, Dennis E.
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (11) : 2099 - 2109
  • [9] Multifunctional cationic polyurethanes designed for non-viral cancer gene therapy
    Cheng, Jian
    Tang, Xin
    Zhao, Jie
    Shi, Ting
    Zhao, Peng
    Lin, Chao
    [J]. ACTA BIOMATERIALIA, 2016, 30 : 155 - 167
  • [10] Therapeutic nanoparticles for drug delivery in cancer
    Cho, Kwangjae
    Wang, Xu
    Nie, Shuming
    Chen, Zhuo
    Shin, Dong M.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1310 - 1316